Skip to content
healthcare.dev

LACOSAMIDE

NDC 70771-1682, Lacosamide, injection, from Zydus Lifesciences Limited.

Product NDC
70771-1682
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209465
DEA schedule
CV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1682 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LACOSAMIDE10 mg/mL

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
70771-1682-67077116820610 VIAL in 1 CARTON (70771-1682-6) / 20 mL in 1 VIAL (70771-1682-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3bc84c70-bc1d-4a72-bbe7-86f32cd646d0

Use it

Look up 70771-1682 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1682 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70771-1682. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.